The discussion opens with a broad overview of seizure burden in grade 2 IDH-mutant glioma, highlighting how epilepsy affects quality of life, long-term disease management, and day-to-day functioning throughout the disease course.
Special Report - Beyond Tumor Control: How Vorasidenib May Impact Seizures in Glioma
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Donanemab Shows Durable Amyloid Clearance and Consistent Safety in Early-Start Patients
2
Understanding the Mechanism and Therapeutic Potential of Vidofludimus Calcium for Multiple Sclerosis
3
Improving Stability with Advanced Therapies in Parkinson’s Disease
4
Parkinson’s Disease Impact on Daily Life and Family Burden
5